Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04c3dcc2e3046dc9ca3a8dbd5f5b41ce |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-17 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-117 |
filingDate |
2009-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2da474cc7f798bb053e292f9afdb0217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78e36454e6a3513dee171d5e06cdb733 |
publicationDate |
2020-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2764396-T3 |
titleOfInvention |
EGFR-targeting double-stranded RNA vector for systemic cancer treatment |
abstract |
A pharmaceutical composition for systemic administration, comprising a pharmaceutically acceptable carrier and an EGFR targeting vector comprising a double-stranded(ds)RNA molecule, a dsRNA carrier and an EGFR binding peptide or polypeptide, wherein said targeting vehicle dsRNA is linear polyethyleneimine covalently linked to polyethylene glycol (PEG), and wherein said dsRNA molecule is non-covalently attached to said dsRNA carrier. |
priorityDate |
2008-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |